You have free access to this content

Hepatology

Cover image for Hepatology

June 2009

Volume 49, Issue 6

Pages 1785–2132

  1. Special Tribute

    1. Top of page
    2. Special Tribute
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Rapid Communication
    12. AASLD Practice Guideline
    13. Special Articles
    14. Image of the Month
    15. Hepatology Elsewhere
    16. Correspondence
    1. You have free access to this content
  2. Comments from the Editors

    1. Top of page
    2. Special Tribute
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Rapid Communication
    12. AASLD Practice Guideline
    13. Special Articles
    14. Image of the Month
    15. Hepatology Elsewhere
    16. Correspondence
    1. You have free access to this content
      Impact factor: Misused and overhyped? (pages 1787–1789)

      Patrick S. Kamath and Gregory Bologna

      Article first published online: 22 APR 2009 | DOI: 10.1002/hep.23040

  3. Editorials

    1. Top of page
    2. Special Tribute
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Rapid Communication
    12. AASLD Practice Guideline
    13. Special Articles
    14. Image of the Month
    15. Hepatology Elsewhere
    16. Correspondence
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
  4. Viral Hepatitis

    1. Top of page
    2. Special Tribute
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Rapid Communication
    12. AASLD Practice Guideline
    13. Special Articles
    14. Image of the Month
    15. Hepatology Elsewhere
    16. Correspondence
    1. You have free access to this content
    2. You have free access to this content
      Nonstructural 3/4A protease of hepatitis C virus activates epithelial growth factor–induced signal transduction by cleavage of the T-cell protein tyrosine phosphatase (pages 1810–1820)

      Erwin Daniel Brenndörfer, Juliane Karthe, Lars Frelin, Patricia Cebula, Andreas Erhardt, Jan Schulte am Esch, Hartmut Hengel, Ralf Bartenschlager, Matti Sällberg, Dieter Häussinger and Johannes Georg Bode

      Article first published online: 23 JAN 2009 | DOI: 10.1002/hep.22857

    3. You have free access to this content
      SAFE biopsy: A validated method for large-scale staging of liver fibrosis in chronic hepatitis C (pages 1821–1827)

      Giada Sebastiani, Philippe Halfon, Laurent Castera, Stanislas Pol, David L. Thomas, Alessandra Mangia, Vito Di Marco, Mario Pirisi, Mihai Voiculescu, Maria Guido, Marc Bourliere, Franco Noventa and Alfredo Alberti

      Article first published online: 2 FEB 2009 | DOI: 10.1002/hep.22859

    4. You have free access to this content
      Evolution of hepatic steatosis in patients with advanced hepatitis C: Results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial (pages 1828–1837)

      Anna S. Lok, James E. Everhart, Raymond T. Chung, Hae-Young Kim, Gregory T. Everson, John C. Hoefs, Joel K. Greenson, Richard K. Sterling, Karen L. Lindsay, William M. Lee, Adrian M. Di Bisceglie, Herbert L. Bonkovsky, Marc G. Ghany, Chihiro Morishima and HALT-C Trial Group

      Article first published online: 2 FEB 2009 | DOI: 10.1002/hep.22865

    5. You have free access to this content
      Retreating chronic hepatitis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin: DIRECT results (pages 1838–1846)

      Bruce R. Bacon, Mitchell L. Shiffman, Flavia Mendes, Reem Ghalib, Tarek Hassanein, Giuseppe Morelli, Shobha Joshi, Kenneth Rothstein, Paul Kwo and Norman Gitlin

      Article first published online: 2 FEB 2009 | DOI: 10.1002/hep.22871

    6. You have free access to this content
      Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial (pages 1847–1858)

      Tania Mara Welzel, Timothy R. Morgan, Herbert L. Bonkovsky, Deepa Naishadham, Ruth M. Pfeiffer, Elizabeth C. Wright, Amy A. Hutchinson, Andrew T. Crenshaw, Arman Bashirova, Mary Carrington, Myhanh Dotrang, Richard K. Sterling, Karen L. Lindsay, Robert J. Fontana, William M. Lee, Adrian M. Di Bisceglie, Marc G. Ghany, David R. Gretch, Stephen J. Chanock, Raymond T. Chung, Thomas R. O'Brien and HALT-C Trial Group

      Article first published online: 2 FEB 2009 | DOI: 10.1002/hep.22877

    7. You have free access to this content
    8. You have free access to this content
      Characterization of occult hepatitis B virus strains in south african blood donors (pages 1868–1876)

      Jean-Pierre Allain, Dalila Belkhiri, Marion Vermeulen, Robert Crookes, Russell Cable, Azin Amiri, Ravi Reddy, Arthur Bird and Daniel Candotti

      Article first published online: 2 FEB 2009 | DOI: 10.1002/hep.22879

  5. Steatohepatitis/Metabolic Liver Disease

    1. Top of page
    2. Special Tribute
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Rapid Communication
    12. AASLD Practice Guideline
    13. Special Articles
    14. Image of the Month
    15. Hepatology Elsewhere
    16. Correspondence
    1. You have free access to this content
      Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease (pages 1877–1887)

      Luca Miele, Venanzio Valenza, Giuseppe La Torre, Massimo Montalto, Giovanni Cammarota, Riccardo Ricci, Roberta Mascianà, Alessandra Forgione, Maria L. Gabrieli, Germano Perotti, Fabio M. Vecchio, Gianlodovico Rapaccini, Giovanni Gasbarrini, Chris P. Day and Antonio Grieco

      Article first published online: 23 JAN 2009 | DOI: 10.1002/hep.22848

    2. You have free access to this content
      Intramitochondrial crystalline inclusions in nonalcoholic steatohepatitis (pages 1888–1895)

      Stephen H. Caldwell, Luiz Antonio R. de Freitas, Sang H. Park, Maria Lucia V. Moreno, Jan A. Redick, Christine A. Davis, Barbee J. Sisson, James T. Patrie, Helma Cotrim, Curtis K. Argo and Abdullah Al-Osaimi

      Article first published online: 23 JAN 2009 | DOI: 10.1002/hep.22851

    3. You have free access to this content
      Glucose dysregulation and hepatic steatosis in obese adolescents: Is there a link? (pages 1896–1903)

      Anna M.G. Cali, Ana Mayra De Oliveira, Hyeonjin Kim, Shu Chen, Miguel Reyes-Mugica, Sandra Escalera, James Dziura, Sara E. Taksali, Romy Kursawe, Melissa Shaw, Mary Savoye, Bridget Pierpont, R. Todd Constable and Sonia Caprio

      Article first published online: 23 JAN 2009 | DOI: 10.1002/hep.22858

    4. You have free access to this content
      Quality of life in adults with nonalcoholic fatty liver disease: Baseline data from the nonalcoholic steatohepatitis clinical research network (pages 1904–1912)

      Kristin David, Kris V. Kowdley, Aynur Unalp, Fasiha Kanwal, Elizabeth M. Brunt, Jeffrey B. Schwimmer and NASH CRN Research Group

      Article first published online: 2 FEB 2009 | DOI: 10.1002/hep.22868

    5. You have free access to this content
    6. You have free access to this content
      Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease (pages 1926–1934)

      Kerry-Lee Milner, David van der Poorten, Aimin Xu, Elisabetta Bugianesi, James G. Kench, Karen S. L. Lam, Donald J. Chisholm and Jacob George

      Article first published online: 9 FEB 2009 | DOI: 10.1002/hep.22896

  6. Hepatobiliary Malignancies

    1. Top of page
    2. Special Tribute
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Rapid Communication
    12. AASLD Practice Guideline
    13. Special Articles
    14. Image of the Month
    15. Hepatology Elsewhere
    16. Correspondence
    1. You have free access to this content
      Overexpression of insulin receptor substrate-1 and hepatitis Bx genes causes premalignant alterations in the liver (pages 1935–1943)

      Lisa Longato, Suzanne de la Monte, Noriyoshi Kuzushita, Masayoshi Horimoto, Arlin B. Rogers, Betty L. Slagle and Jack R. Wands

      Article first published online: 23 JAN 2009 | DOI: 10.1002/hep.22856

    2. You have free access to this content
      Inhibition of c-Jun NH2-terminal kinase switches Smad3 signaling from oncogenesis to tumor- suppression in rat hepatocellular carcinoma (pages 1944–1953)

      Hiromitsu Nagata, Etsuro Hatano, Masaharu Tada, Miki Murata, Koji Kitamura, Hiroyuki Asechi, Masato Narita, Atsuko Yanagida, Nobuyuki Tamaki, Shintaro Yagi, Iwao Ikai, Koichi Matsuzaki and Shinji Uemoto

      Article first published online: 2 FEB 2009 | DOI: 10.1002/hep.22860

    3. You have free access to this content
      Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography (pages 1954–1961)

      Ryota Masuzaki, Ryosuke Tateishi, Haruhiko Yoshida, Eriko Goto, Takahisa Sato, Takamasa Ohki, Jun Imamura, Tadashi Goto, Fumihiko Kanai, Naoya Kato, Hitoshi Ikeda, Shuichiro Shiina, Takao Kawabe and Masao Omata

      Article first published online: 2 FEB 2009 | DOI: 10.1002/hep.22870

    4. You have free access to this content
      Enhanced expression of vascular endothelial growth factor-A in ground glass hepatocytes and its implication in hepatitis B virus hepatocarcinogenesis (pages 1962–1971)

      Jui-Chu Yang, Chiao-Fang Teng, Han-Chieh Wu, Hung-Wen Tsai, Huai-Chia Chuang, Ting-Fen Tsai, Yung-Hsiang Hsu, Wenya Huang, Li-Wha Wu and Ih-Jen Su

      Article first published online: 9 FEB 2009 | DOI: 10.1002/hep.22889

  7. Autoimmune, Cholestatic and Biliary Disease

    1. Top of page
    2. Special Tribute
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Rapid Communication
    12. AASLD Practice Guideline
    13. Special Articles
    14. Image of the Month
    15. Hepatology Elsewhere
    16. Correspondence
    1. You have free access to this content
      Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2−/− mice (pages 1972–1981)

      Emina Halilbasic, Romina Fiorotto, Peter Fickert, Hanns-Ulrich Marschall, Tarek Moustafa, Carlo Spirli, Andrea Fuchsbichler, Judith Gumhold, Dagmar Silbert, Kurt Zatloukal, Cord Langner, Uday Maitra, Helmut Denk, Alan F. Hofmann, Mario Strazzabosco and Michael Trauner

      Article first published online: 8 FEB 2009 | DOI: 10.1002/hep.22891

    2. You have free access to this content
      Dysregulation of glutathione synthesis during cholestasis in mice: Molecular mechanisms and therapeutic implications (pages 1982–1991)

      Heping Yang, Komal Ramani, Meng Xia, Kwang Suk Ko, Tony W.H. Li, Pilsoo Oh, Jiaping Li and Shelly C. Lu

      Article first published online: 11 FEB 2009 | DOI: 10.1002/hep.22908

  8. Liver Injury/Regeneration

    1. Top of page
    2. Special Tribute
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Rapid Communication
    12. AASLD Practice Guideline
    13. Special Articles
    14. Image of the Month
    15. Hepatology Elsewhere
    16. Correspondence
    1. You have free access to this content
    2. You have free access to this content
      Phenotypic characterization of idiosyncratic drug-induced liver injury: The influence of age and sex (pages 2001–2009)

      M. Isabel Lucena, Raúl J. Andrade, Neil Kaplowitz, Miren García-Cortes, M. Carmen Fernández, Manuel Romero-Gomez, Miguel Bruguera, Hacibe Hallal, Mercedes Robles-Diaz, Jose F. Rodriguez-González, Jose Maria Navarro, Javier Salmeron, Pedro Martinez-Odriozola, Ramón Pérez-Alvarez, Yolanda Borraz, Ramón Hidalgo and Spanish Group for the Study of Drug-Induced Liver Disease

      Article first published online: 9 FEB 2009 | DOI: 10.1002/hep.22895

    3. You have free access to this content
  9. Liver Biology/Pathobiology

    1. Top of page
    2. Special Tribute
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Rapid Communication
    12. AASLD Practice Guideline
    13. Special Articles
    14. Image of the Month
    15. Hepatology Elsewhere
    16. Correspondence
    1. You have free access to this content
    2. You have free access to this content
      Extracellular matrix modulates sensitivity of hepatocytes to fibroblastoid dedifferentiation and transforming growth factor β–induced apoptosis (pages 2031–2043)

      Patricio Godoy, Jan G. Hengstler, Iryna Ilkavets, Christoph Meyer, Anastasia Bachmann, Alexandra Müller, Gregor Tuschl, Stefan O. Mueller and Steven Dooley

      Article first published online: 2 FEB 2009 | DOI: 10.1002/hep.22880

    3. You have free access to this content
      Novel mechanism of C-reactive protein for enhancing mouse liver innate immunity (pages 2044–2054)

      Akihito Inatsu, Manabu Kinoshita, Hiroyuki Nakashima, Jun Shimizu, Daizoh Saitoh, Seiichi Tamai and Shuhji Seki

      Article first published online: 7 APR 2009 | DOI: 10.1002/hep.22888

    4. You have free access to this content
      Hepatic stellate cells express functional CXCR4: Role in stromal cell–derived factor-1α–mediated stellate cell activation (pages 2055–2067)

      Feng Hong, Ana Tuyama, Ting Fang Lee, Johnny Loke, Ritu Agarwal, Xin Cheng, Anita Garg, M. Isabel Fiel, Myron Schwartz, Jose Walewski, Andrea Branch, Alison D. Schecter and Meena B. Bansal

      Article first published online: 9 FEB 2009 | DOI: 10.1002/hep.22890

    5. You have free access to this content
      A novel pregnane X receptor and S14-mediated lipogenic pathway in human hepatocyte (pages 2068–2079)

      Amélie Moreau, Christelle Téruel, Michel Beylot, Valérie Albalea, Viola Tamasi, Thierry Umbdenstock, Yannick Parmentier, Antonio Sa-Cunha, Bertrand Suc, Jean-Michel Fabre, Francis Navarro, Jeanne Ramos, Urs Meyer, Patrick Maurel, Marie-José Vilarem and Jean-Marc Pascussi

      Article first published online: 11 FEB 2009 | DOI: 10.1002/hep.22907

  10. Rapid Communication

    1. Top of page
    2. Special Tribute
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Rapid Communication
    12. AASLD Practice Guideline
    13. Special Articles
    14. Image of the Month
    15. Hepatology Elsewhere
    16. Correspondence
    1. You have free access to this content
      Long-term therapy with clevudine for chronic hepatitis B can be associated with myopathy characterized by depletion of mitochondrial DNA (pages 2080–2086)

      Jung Im Seok, Dong Kuck Lee, Chang Hyeong Lee, Min Su Park, Sun Young Kim, Hyang-Sook Kim, Hee-Young Jo, Chang Hun Lee and Dae-Seong Kim

      Article first published online: 29 MAR 2009 | DOI: 10.1002/hep.22959

  11. AASLD Practice Guideline

    1. Top of page
    2. Special Tribute
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Rapid Communication
    12. AASLD Practice Guideline
    13. Special Articles
    14. Image of the Month
    15. Hepatology Elsewhere
    16. Correspondence
    1. You have free access to this content
  12. Special Articles

    1. Top of page
    2. Special Tribute
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Rapid Communication
    12. AASLD Practice Guideline
    13. Special Articles
    14. Image of the Month
    15. Hepatology Elsewhere
    16. Correspondence
    1. You have free access to this content
  13. Image of the Month

    1. Top of page
    2. Special Tribute
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Rapid Communication
    12. AASLD Practice Guideline
    13. Special Articles
    14. Image of the Month
    15. Hepatology Elsewhere
    16. Correspondence
    1. You have free access to this content
      The pineapple upside-down liver cake (pages 2113–2114)

      Anthony W. Castleberry, David A. Geller and Allan Tsung

      Article first published online: 28 MAY 2009 | DOI: 10.1002/hep.22958

  14. Hepatology Elsewhere

    1. Top of page
    2. Special Tribute
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Rapid Communication
    12. AASLD Practice Guideline
    13. Special Articles
    14. Image of the Month
    15. Hepatology Elsewhere
    16. Correspondence
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
      When sleeping beauty wakes up and jumps into a cancer-minded environment (pages 2122–2124)

      Ralf Weiskirchen, Christian Liedtke and Christian Trautwein

      Article first published online: 28 MAY 2009 | DOI: 10.1002/hep.23030

  15. Correspondence

    1. Top of page
    2. Special Tribute
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Rapid Communication
    12. AASLD Practice Guideline
    13. Special Articles
    14. Image of the Month
    15. Hepatology Elsewhere
    16. Correspondence
    1. You have free access to this content
    2. You have free access to this content
      Reply: (pages 2125–2126)

      Akihiro Matsumoto and Eiji Tanaka

      Article first published online: 28 MAY 2009 | DOI: 10.1002/hep.22961

    3. You have free access to this content
    4. You have free access to this content
      Reply: (page 2126)

      Marina Berenguer

      Article first published online: 6 APR 2009 | DOI: 10.1002/hep.22967

    5. You have free access to this content
      Orlistat for overweight subjects with nonalcoholic steatohepatitis (page 2127)

      Teoman Dogru, Cemal Nuri Ercin, Ilker Tasci, Serkan Tapan, Zeki Yesilova and Ahmet Uygun

      Article first published online: 6 JAN 2009 | DOI: 10.1002/hep.22822

    6. You have free access to this content
      Reply: (pages 2127–2128)

      Stephen Harrison, Brent Neuschwander-Tetri and Elizabeth Brunt

      Article first published online: 28 MAY 2009 | DOI: 10.1002/hep.22968

    7. You have free access to this content
      Hepatitis C virus replication in patients with occult hepatitis C virus infection (pages 2128–2129)

      Vicente Carreño, Javier Bartolomé, Inmaculada Castillo and Juan Antonio Quiroga

      Article first published online: 7 APR 2009 | DOI: 10.1002/hep.22936

    8. You have free access to this content
      Reply: (page 2129)

      Martin-Walter Welker and Stefan Zeuzem

      Article first published online: 6 APR 2009 | DOI: 10.1002/hep.22966

    9. You have free access to this content
      Phenotypic differences between two Gnmt−/− mouse models for hepatocellular carcinoma (pages 2130–2131)

      Yi-Ming Arthur Chen, Yi-Jen Liao, Shih-Ping Liu and Ting-Fen Tsai

      Article first published online: 6 APR 2009 | DOI: 10.1002/hep.22984

    10. You have free access to this content
      Reply: (page 2131)

      Zigmund Luka, M. Luz Martínez-Chantar, Shelly C. Lu, Conrad Wager and José M. Mato

      Article first published online: 28 MAY 2009 | DOI: 10.1002/hep.22997

    11. You have free access to this content
    12. You have free access to this content
      Reply: (page 2132)

      Yasuji Arase

      Article first published online: 6 APR 2009 | DOI: 10.1002/hep.23005

SEARCH

SEARCH BY CITATION